KE3649D - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- KE3649D KE3649D KE3649BD KE364986D KE3649D KE 3649 D KE3649 D KE 3649D KE 3649B D KE3649B D KE 3649BD KE 364986 D KE364986 D KE 364986D KE 3649 D KE3649 D KE 3649D
- Authority
- KE
- Kenya
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7910558 | 1979-03-27 | ||
GB7939505 | 1979-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
KE3649D true KE3649D (en) | 1986-08-01 |
Family
ID=26271029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KE3649BD KE3649D (en) | 1979-03-27 | 1986-07-08 | Therapeutic agents |
Country Status (34)
Country | Link |
---|---|
US (1) | US4302460A (de) |
KR (1) | KR840001612B1 (de) |
AT (1) | AT379390B (de) |
AU (1) | AU536616B2 (de) |
BG (2) | BG37836A3 (de) |
CA (1) | CA1151652A (de) |
CH (1) | CH644366A5 (de) |
CS (1) | CS221906B2 (de) |
DD (1) | DD149608A5 (de) |
DE (2) | DE3051205C2 (de) |
DK (1) | DK151252C (de) |
EG (1) | EG16606A (de) |
FI (1) | FI77026C (de) |
FR (2) | FR2452484A1 (de) |
GR (1) | GR68007B (de) |
HK (1) | HK94986A (de) |
HU (1) | HU179845B (de) |
IE (1) | IE49562B1 (de) |
IL (1) | IL59710A (de) |
IT (1) | IT1188916B (de) |
KE (1) | KE3649D (de) |
LU (1) | LU82295A1 (de) |
MX (1) | MX6816E (de) |
MY (1) | MY8600668A (de) |
NL (1) | NL191306C (de) |
NO (1) | NO156787C (de) |
NZ (1) | NZ193167A (de) |
PH (1) | PH16758A (de) |
PL (1) | PL124037B1 (de) |
PT (1) | PT71006A (de) |
RO (1) | RO79397A (de) |
SE (1) | SE455422B (de) |
SG (1) | SG60886G (de) |
YU (1) | YU42332B (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE51542B1 (en) * | 1980-09-26 | 1987-01-07 | Boots Co Ltd | Therapeutic agents |
PT79031B (en) * | 1983-08-20 | 1986-08-22 | Boots Co Plc | Therapeutic agents |
EP0149519B1 (de) * | 1984-01-13 | 1990-06-27 | The Boots Company PLC | Verwendung von Chinolonen für die Herstellung eines Arzneimittels zur Behandlung von Herzerkrankungen. |
DE3576686D1 (de) * | 1984-08-15 | 1990-04-26 | Boots Co Ltd | Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate. |
GB8515209D0 (en) * | 1985-06-15 | 1985-07-17 | Boots Co Plc | Therapeutic agents |
GB8515207D0 (en) * | 1985-06-15 | 1985-07-17 | Boots Co Plc | Therapeutic agents |
GB8627698D0 (en) * | 1986-11-20 | 1986-12-17 | Boots Co Plc | Therapeutic agents |
GB8726950D0 (en) * | 1987-11-18 | 1987-12-23 | Boots Co Plc | Chemical process |
GB8804016D0 (en) * | 1988-02-22 | 1988-03-23 | Boots Co Plc | Therapeutic agents |
GB8918952D0 (en) * | 1989-08-19 | 1989-10-04 | Boots Co Plc | Therapeutic agents |
IL100555A (en) * | 1991-02-07 | 2000-08-31 | Hoechst Marion Roussel Inc | N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them |
FR2684671B1 (fr) * | 1991-11-20 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la quinoleine, leur procede de preparation et intermediaires et leur application a titre de medicaments. |
FR2672597B1 (fr) * | 1991-02-07 | 1995-05-19 | Roussel Uclaf | Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
FR2680511B1 (fr) * | 1991-08-20 | 1995-05-19 | Roussel Uclaf | Derives n-substitues de la quinoleine, leur procede de preparation, intermediaires obtenus, leur application comme medicaments et les compositions les renfermant. |
JP2002522388A (ja) * | 1998-08-03 | 2002-07-23 | ビーエーエスエフ コーポレーション | 性機能障害の治療のためのピリジノン |
US6307050B1 (en) * | 2000-08-29 | 2001-10-23 | R. T. Alamo Venture I Llc | Method of synthesizing flosequinan from 4-fluoroanthranilic acid |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
US6562838B2 (en) | 2001-01-26 | 2003-05-13 | R. T. Alamo Ventures I, L.L.C. | Treatment of cardiovascular disease with quinolinone enantiomers |
US6458804B1 (en) | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
US6649764B2 (en) * | 2001-10-25 | 2003-11-18 | R. T. Alamo Ventures I, Llc | Stereospecific enrichment of heterocyclic enantiomers |
US6730790B2 (en) * | 2002-03-01 | 2004-05-04 | R.T. Alamo Ventures I. Llc | Chlorinated heterocyclic compounds and methods of synthesis |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3178348A (en) * | 1961-02-08 | 1965-04-13 | Norwich Pharma Co | Hypotensive quinolines |
GB1066917A (en) | 1964-04-03 | 1967-04-26 | Hoffmann La Roche | Novel isoquinoline derivatives and a process for the manufacture thereof |
DE1770482A1 (de) * | 1968-05-22 | 1971-11-11 | Basf Ag | Verfahren zur Herstellung von 2,4-Dioxychinolinen |
US3798219A (en) * | 1971-10-18 | 1974-03-19 | Warner Lambert Co | 3-(methylsulfinyl)cinnolinones and their derivatives |
US3772301A (en) * | 1971-11-22 | 1973-11-13 | Warner Lambert Co | (4-substituted)4-(methylsulfinyl)methylcarbostyrils |
CH607848A5 (de) * | 1974-06-04 | 1978-11-30 | Bayer Ag | |
GB1488411A (en) * | 1975-01-16 | 1977-10-12 | Wyeth John & Brother Ltd | 3,4-dihydro-4-arylquinolin-4-ol derivatives |
US4124587A (en) * | 1976-03-01 | 1978-11-07 | Sandoz, Inc. | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones |
US4127574A (en) * | 1976-03-01 | 1978-11-28 | Sandoz, Inc. | 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones |
DE2616995A1 (de) | 1976-04-17 | 1977-10-27 | Bayer Ag | 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2616991A1 (de) | 1976-04-17 | 1977-10-27 | Bayer Ag | Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2639257A1 (de) | 1976-09-01 | 1978-03-02 | Bayer Ag | Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2639498A1 (de) | 1976-09-02 | 1978-03-09 | Bayer Ag | Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2641746C2 (de) | 1976-09-16 | 1986-11-06 | Bayer Ag, 5090 Leverkusen | 1,4-Dihydropyridin-Zuckerderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2658804A1 (de) | 1976-12-24 | 1978-07-06 | Bayer Ag | Kreislaufbeeinflussende mittel |
DE2715182A1 (de) | 1977-04-05 | 1978-10-19 | Bayer Ag | 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US4177278A (en) * | 1977-04-05 | 1979-12-04 | Bayer Aktiengesellschaft | 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use |
JPS5424882A (en) | 1977-07-22 | 1979-02-24 | Yamanouchi Pharmaceut Co Ltd | Novel heterocyclic compounds and their preparation |
DE2747513A1 (de) | 1977-10-22 | 1979-05-03 | Bayer Ag | Dihydropyridine mit schwefelhaltigen estergruppierungen |
-
1980
- 1980-03-18 NZ NZ193167A patent/NZ193167A/en unknown
- 1980-03-19 IE IE567/80A patent/IE49562B1/en not_active IP Right Cessation
- 1980-03-21 AU AU56702/80A patent/AU536616B2/en not_active Ceased
- 1980-03-22 GR GR61514A patent/GR68007B/el unknown
- 1980-03-24 US US06/133,310 patent/US4302460A/en not_active Expired - Lifetime
- 1980-03-24 PH PH23802A patent/PH16758A/en unknown
- 1980-03-25 IL IL59710A patent/IL59710A/xx not_active IP Right Cessation
- 1980-03-25 PT PT71006A patent/PT71006A/pt not_active IP Right Cessation
- 1980-03-25 FI FI800923A patent/FI77026C/fi not_active IP Right Cessation
- 1980-03-25 RO RO80100611A patent/RO79397A/ro unknown
- 1980-03-25 LU LU82295A patent/LU82295A1/fr unknown
- 1980-03-26 BG BG047135A patent/BG37836A3/xx unknown
- 1980-03-26 NO NO800881A patent/NO156787C/no unknown
- 1980-03-26 CA CA000348520A patent/CA1151652A/en not_active Expired
- 1980-03-26 DK DK130180A patent/DK151252C/da not_active IP Right Cessation
- 1980-03-26 YU YU849/80A patent/YU42332B/xx unknown
- 1980-03-26 BG BG066170A patent/BG37993A3/xx unknown
- 1980-03-26 AT AT0161880A patent/AT379390B/de not_active IP Right Cessation
- 1980-03-26 CH CH237680A patent/CH644366A5/fr not_active IP Right Cessation
- 1980-03-26 SE SE8002345A patent/SE455422B/sv not_active IP Right Cessation
- 1980-03-26 NL NL8001771A patent/NL191306C/xx not_active IP Right Cessation
- 1980-03-26 KR KR1019800001266A patent/KR840001612B1/ko active
- 1980-03-26 HU HU8080713A patent/HU179845B/hu not_active IP Right Cessation
- 1980-03-26 IT IT48262/80A patent/IT1188916B/it active
- 1980-03-27 PL PL1980223050A patent/PL124037B1/pl unknown
- 1980-03-27 DE DE19803051205 patent/DE3051205C2/de not_active Expired - Lifetime
- 1980-03-27 FR FR8006811A patent/FR2452484A1/fr active Granted
- 1980-03-27 MX MX808725U patent/MX6816E/es unknown
- 1980-03-27 DD DD80219973A patent/DD149608A5/de not_active IP Right Cessation
- 1980-03-27 CS CS802156A patent/CS221906B2/cs unknown
- 1980-03-27 DE DE19803011994 patent/DE3011994A1/de active Granted
- 1980-03-29 EG EG188/80A patent/EG16606A/xx active
- 1980-10-02 FR FR8021107A patent/FR2468367A1/fr active Granted
-
1986
- 1986-07-08 KE KE3649BD patent/KE3649D/xx unknown
- 1986-07-10 SG SG608/86A patent/SG60886G/en unknown
- 1986-12-04 HK HK949/86A patent/HK94986A/xx not_active IP Right Cessation
- 1986-12-30 MY MY668/86A patent/MY8600668A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA801328B (en) | Therapeutic agents | |
GB2000136B (en) | Therapeutic agents | |
GB2005248B (en) | Therapeutic agents | |
ZA782816B (en) | Therapeutic agents | |
ZA80298B (en) | Therapeutic agents | |
GB2000138B (en) | Therapeutic agents | |
ZA796708B (en) | Therapeutic agents | |
GB2000131B (en) | Therapeutic agents | |
EG16606A (en) | Therapeutic agents | |
ZA792390B (en) | Therapeutic agents | |
GB2013181B (en) | Therapeutic agents | |
GB2004876B (en) | Therapeutic agents | |
GB2007656B (en) | Therapeutic agents | |
GB2019836B (en) | Therapeutic agents | |
GB2053910B (en) | Pyridylaminotriazole therapeutic agents | |
GB2047691B (en) | Therapeutic agents | |
GB2000510B (en) | Therapeutic agents | |
GB2011890B (en) | Therapeutic agents | |
GB2010824B (en) | Therapeutic agents | |
GB2013179B (en) | Therapeutic agents | |
GB2011891B (en) | Therapeutic agents | |
GB2008104B (en) | Therapeutic agents | |
GB2007654B (en) | Therapeutic agents | |
ZA803988B (en) | Novel therapeutic combinations | |
GB2009156B (en) | Therapeutic agents |